Partner With Us
Together we will find future cures to disease
At Exscalate we collaborate with our partners. Together we can accelerate drug discovery programs to reach the goal we are all working towards - delivering effective treatments to patients, faster.
The EXSCALATE difference
The power of Exscalate is unprecedented.
Our virtual screening platform consists of the world’s largest ligand library of over 2 trillion organic chemistry molecules. Leveraging unlimited supercomputing resources together with big data analytics and AI we evaluate these molecules at a rate of up to 60 million per second for each new target.
This rapid simulation of how molecules interact with the human body’s complex biochemistry means that many hypotheses can be generated and tested in our platform. This accelerated process of drug design and testing delivers safe, precise and effective results.
Collaborative drug programs
We are more than a tool. We embark on the drug discovery journey with our partners. Together we are identifying novel drug candidates for a range of complex biological targets across multiple therapeutic areas. Whether it’s new drug design or drug repurposing strategies, our platform is accelerating projects through the drug discovery process towards clinical trials. The Exscalate platform has helped boost the identification of drug candidates for multiple validated targets, including some ongoing late-stage clinical trials in disease areas such as viral infection, ophthalmology, oncology and immune disease.
Working together to fight pandemics
In 2020, Exscalate led the public-private consortium, Exscalate4CoV. Bringing together 18 institutions and research centers across Europe, these partners leveraged the power of Exscalate’s supercomputing AI-driven platform in the fight against COVID-19.
In just four months a low molecular weight negative allosteric modulator, Raloxifene, was identified and successfully entered Phase III clinical trials.
This rapid simulation of how molecules interact with the human body’s complex biochemistry means that many hypotheses can be generated and tested in our platform. This accelerated process of drug design and testing delivers safe, precise and effective results.
Partner with us
If drug discovery is a race, it’s not one that you can win alone. Drug discovery is complex and challenging. That’s why at Exscalate we adopt an open innovation approach. We know that collaboration is the most effective way to address the challenges of drug discovery.
Through partnerships with academic institutions, industry players, biopharma start-ups and research networks we embark on the drug discovery journey together. In partnership we will finish the race faster and more successfully.
We have the utmost confidence in our platform and look forward to harnessing its power to deliver precision results for our partners. Let us work together to prove what it is capable of.
Please fill in this field.
Please fill in this field.
Please fill in this field.
Please fill in this field.
Please fill in this field.
Partnerships
We have formed many successful partnerships. Together we are accelerating drug discovery.